TWiV 868: COVID-19 clinical update #102 with Dr. Daniel Griffin
Feb 19, 2022•46 min•Ep. 868
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #102, Daniel Griffin reviews children and COVID, effectiveness of maternal vaccination, vaccines for immunocompromised, primary care physicians and vaccination rates, booster safety among adults, placentitis, azithromycin, oral Nirmatrelvir, Omicron antibody evasion, EUA for bebtelovimab, IL-1 blocking agents, thromboprophylaxis, effectiveness of vaccines against long COVID, and risks of mental health outcomes.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Children and COVID state data (AAP)
- Effectiveness of maternal vaccination (MMWR)
- Vaccines for immunocompromised (CDC)
- PCP and vaccination rates (JAMA)
- Booster safety among adults (MMWR)
- Placental tissue destruction and placentitis (Arch Path Lab Med)
- Azithromycin meta-analysis (J Antimicrob Chemo)
- Oral Nirmatrelvir for high-risk, nonhospitalized adults (NEJM)
- Omicron antibody evasion (bioRxiv)
- EUA for bebtelovimab (FDA)
- IL-1 blocking agents (Cochrane)
- Thromboprophylaxis (Chest)
- Effectiveness of vaccines against long COVID (UK Health)
- COVID complications in Australia (Lancet)
- Risks of mental health outcomes (BMJ)
- Letters read on TWiV 868
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android